Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price Near 52-Week High on 3.11% Rise
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Share Price is Rs 2,878, up 3.11%, and trading near its 52-week high with a market capitalisation of Rs 21,125.93 Cr.
Caplin Point Laboratories Share Price is trading at Rs 2,878, up 3.11% from the previous close of Rs 2,791.3, and is staying close to its 52-week high during the current market session. The company’s market capitalisation stands at Rs 21,125.93 Cr, placing the move in a large listed healthcare franchise with meaningful size on the Indian stock market. According to latest Univest data, the stock opened at Rs 2,777.9, touched a high of Rs 2,990.6 and a low of Rs 2,770, while turnover stood at Rs 14.26 Cr. The latest Univest figures confirm the price event, but do not establish a company-specific catalyst. Caplin Point Laboratories Share Price is therefore in focus today because the stock is trading near its yearly high while investors track the valuation backdrop, profitability ratios and healthcare sector context.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,878 |
| Previous Close | Rs 2,791.3 |
| Today's Move | +Rs 86.7 (+3.11%) |
| Open | Rs 2,777.9 |
| High | Rs 2,990.6 |
| Low | Rs 2,770 |
| Turnover | Rs 14.26 crore |
| Market Capitalisation | Rs 21,125.93 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) traded at Rs 2,878 versus the previous close of Rs 2,791.3, a rise of 3.11%. The stock opened at Rs 2,777.9, reached a high of Rs 2,990.6 and touched a low of Rs 2,770.
Caplin Point Laboratories Share Price Today shows a move of Rs 86.7 above the previous close, with the stock last traded at Rs 2,878 against an intraday range of Rs 2,770 to Rs 2,990.6. The price is also close to its one-year high, which keeps the stock in today’s stock news flow and among 52 Week High Stocks in the Indian stock market. Turnover at Rs 14.26 Cr gives a factual sense of trading value without implying anything about participation or demand. The day’s opening level at Rs 2,777.9 means the stock moved above the open and above the previous close during the current market session. For readers following Caplin Point Laboratories Share Price Live, the key fact is simple: the stock is trading close to its 52-week peak and is holding a higher price band than yesterday’s settlement.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 21,125.93 crore |
| P/E Ratio | 31.89x |
| P/B Ratio | 5.78x |
| ROE | 20.79% |
| ROCE | 24.97% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 483.17 |
| Dividend Yield | 0.29% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 31.89x, P/B 5.78x, ROE 20.79%, ROCE 24.97%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 21125.93 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.89x, P/B at 5.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.79% and ROCE of 24.97%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 87.53, book value per share of Rs 483.17, dividend yield of 0.29%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.31x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.89x |
| Benchmark Median P/E | 28.31x |
| Benchmark Average P/E | 42.31x |
| Benchmark P/E Range | 0x to 762.66x |
| Company P/B Ratio | 5.78x |
| Benchmark Median P/B | 2.9x |
| Company ROE | 20.79% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 24.97% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 21,125.93 crore |
| Benchmark Median Market Cap | Rs 745.38 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.89x, which is above the benchmark median of 28.31x, a difference of +12.65%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 20.79%, which is above the benchmark median of 11.69%, a difference of +77.84%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 24.97%, which is above the benchmark median of 13.32%, a difference of +87.46%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Shilpa Medicare Ltd. | SHILPAMED | 20,207.51 | 68.22 | 7.55 | 9.82 | 11.43 |
| Granules India Ltd. | GRANULES | 23,581.82 | 35.42 | 4.79 | 14.13 | 15.74 |
| Pfizer Ltd. | PFIZER | 18,274.85 | 25 | 4.17 | 17.16 | 23.39 |
| ONESOURCE SPECL PHARMA L | ONESOURCE | 18,203.75 | 0 | 3.13 | -1.26 | 0.44 |
| Eris Lifesciences Ltd. | ERIS | 17,675.99 | 27.36 | 4.37 | 19.23 | 14.47 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.89x compared with the displayed peer median of 27.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.79% compares with a peer median of 14.13% across the companies shown in the table. ROCE stood at 24.97% versus the displayed peer median of 14.47%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 21,125.93 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories
- Caplin Point Laboratories Share Price is trading at Rs 2,878, near its 52-week high, after a 3.11% rise from the previous close.
- The stock moved between Rs 2,770 and Rs 2,990.6 during the current session, with turnover of Rs 14.26 Cr.
- Market capitalisation stands at Rs 21,125.93 Cr, placing Caplin Point Laboratories among the larger names in the healthcare peer set.
- P/E is 31.89 and P/B is 5.78, both above the same-industry median in the latest Univest figures.
- ROE of 20.79 and ROCE of 24.97 are above the sector medians, while EPS is Rs 87.53 and book value per share is Rs 483.17.
About Caplin Point Laboratories
Caplin Point Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s stock is listed on NSE and BSE under the symbol CAPLIPOINT. In the latest Univest data, the business is tracked with market capitalisation, valuation ratios, earnings per share, book value per share and dividend yield as the main published financial markers. Caplin Point Laboratories Share Price is therefore being followed not only for today’s price movement but also for its place within the pharmaceutical peer group and sector benchmark set.
Frequently Asked Questions
Why is Caplin Point Laboratories Share Price in focus today?
Ans. Caplin Point Laboratories Share Price is in focus because it is trading near its 52-week high at Rs 2,878, up 3.11% from the previous close, with Rs 21,125.93 Cr market capitalisation and Rs 14.26 Cr turnover.
What is Caplin Point Laboratories Share Price today?
Ans. Caplin Point Laboratories Share Price today is Rs 2,878. The stock is above the previous close of Rs 2,791.3 and traded within an intraday range of Rs 2,770 to Rs 2,990.6 during the current market session.
Is Caplin Point Laboratories trading near its 52-week high?
Ans. Yes. Caplin Point Laboratories Share Price is trading close to its 52-week high and one-year high, which is why it appears in near-peak stock scans and healthcare stock updates on Univest.
What valuation metrics stand out in Caplin Point Laboratories Share Price?
How does Caplin Point Laboratories compare with healthcare peers?
Ans. Compared with peers such as Pfizer, Granules India and Eris Lifesciences, Caplin Point Laboratories has a higher market capitalisation than some names and stronger return ratios than several listed peers in the same industry set.
What do EPS and book value show for Caplin Point Laboratories Share Price?
Ans. EPS is Rs 87.53 and book value per share is Rs 483.17. EPS reflects earnings attributable to each share, while book value per share shows the accounting net worth behind each share.
What is the dividend yield for Caplin Point Laboratories?
Ans. Caplin Point Laboratories has a dividend yield of 0.29%. That is a historical payout measure based on the current share price, not a promise of future dividend distributions.
Should investors track Caplin Point Laboratories Stock News?
Ans. Investors tracking Caplin Point Laboratories Stock News can watch price action, valuation metrics, sector comparison and company-specific filings. Univest presents these factors together so readers can follow Caplin Point Laboratories Share Price and related market context efficiently.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Caplin Point Laboratories Share Price on Univest for live share price updates, company news, valuation ratios, sector context, peer comparison, 52-week levels and market insights. Univest also helps readers monitor Caplin Point Laboratories Share Price Today, Caplin Point Laboratories Latest News and Caplin Point Laboratories Stock News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
